LabGen provides advanced infectious disease testing designed to support timely diagnosis, targeted treatment decisions, and improved patient outcomes. As a CLIA-certified high-complexity diagnostic laboratory serving providers nationwide, we deliver precise molecular detection supported by validated instrumentation and strict quality standards.
Our infectious disease division is built on Real-Time PCR technology, ensuring high analytical sensitivity, pathogen-specific detection, and rapid turnaround times across all testing panels.
Traditional culture-based or antigen methods may lack the sensitivity or speed required in acute clinical scenarios. Molecular diagnostics using Real-Time PCR enable direct detection of pathogen-specific genetic material with exceptional accuracy.
24–48 Hours
Our molecular laboratory workflow is optimized for efficient specimen processing and rapid reporting without compromising analytical integrity.
Secure electronic reporting integrates seamlessly into provider workflows.
LabGen combines advanced molecular technology, reliable 24–48 hour turnaround times, and responsive provider support to deliver trusted infectious disease diagnostic solutions nationwide.
Request Infectious Disease InformationLabGen uses Real-Time PCR molecular diagnostics for pathogen detection.
Most infectious disease results are reported within 24–48 hours.
Testing includes respiratory pathogens, gastrointestinal organisms, sexually transmitted infections (STIs), and other bacterial and viral targets.
PCR provides high sensitivity, pathogen-specific detection, and faster results compared to many traditional culture methods.
Yes. Molecular detection identifies pathogen genetic material even at low concentrations.
Yes. Panels may include influenza, RSV, COVID-19, and other respiratory pathogens.
Yes. Rapid identification enables more targeted therapy decisions.
Yes. Secure electronic reporting integrates with provider workflows.
Yes. All molecular testing is conducted under high-complexity laboratory requirements.